WallStSmart

Advanced Energy Industries Inc (AEIS)vsVertex Pharmaceuticals Inc (VRTX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Vertex Pharmaceuticals Inc generates 541% more annual revenue ($12.22B vs $1.91B). VRTX leads profitability with a 35.5% profit margin vs 10.0%. VRTX appears more attractively valued with a PEG of 2.10. VRTX earns a higher WallStSmart Score of 66/100 (B-).

AEIS

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 6.0Value: 3.0Quality: 7.8
Piotroski: 6/9Altman Z: 2.97

VRTX

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.7Quality: 8.0
Piotroski: 3/9Altman Z: 3.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AEIS.

VRTXUndervalued (+56.6%)

Margin of Safety

+56.6%

Fair Value

$989.67

Current Price

$448.29

$541.38 discount

UndervaluedFair: $989.67Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AEIS2 strengths · Avg: 9.0/10
EPS GrowthGrowth
144.8%10/10

Earnings expanding 144.8% YoY

Revenue GrowthGrowth
26.3%8/10

Revenue surging 26.3% year-over-year

VRTX6 strengths · Avg: 9.7/10
Profit MarginProfitability
35.5%10/10

Keeps 36 of every $100 in revenue as profit

Operating MarginProfitability
38.1%10/10

Strong operational efficiency at 38.1%

EPS GrowthGrowth
61.4%10/10

Earnings expanding 61.4% YoY

Altman Z-ScoreHealth
3.6210/10

Safe zone — low bankruptcy risk

Market CapQuality
$107.87B9/10

Large-cap with strong market position

Return on EquityProfitability
24.2%9/10

Every $100 of equity generates 24 in profit

Areas to Watch

AEIS4 concerns · Avg: 2.5/10
Price/BookValuation
9.8x4/10

Trading at 9.8x book value

PEG RatioValuation
2.772/10

Expensive relative to growth rate

P/E RatioValuation
74.1x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-42.60M2/10

Negative free cash flow — burning cash

VRTX3 concerns · Avg: 3.7/10
PEG RatioValuation
2.104/10

Expensive relative to growth rate

P/E RatioValuation
25.3x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AEIS

The strongest argument for AEIS centers on EPS Growth, Revenue Growth. Revenue growth of 26.3% demonstrates continued momentum.

Bull Case : VRTX

The strongest argument for VRTX centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 35.5% and operating margin at 38.1%.

Bear Case : AEIS

The primary concerns for AEIS are Price/Book, PEG Ratio, P/E Ratio. A P/E of 74.1x leaves little room for execution misses.

Bear Case : VRTX

The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

AEIS profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.

AEIS carries more volatility with a beta of 1.40 — expect wider price swings.

AEIS is growing revenue faster at 26.3% — sustainability is the question.

VRTX generates stronger free cash flow (1.3B), providing more financial flexibility.

Bottom Line

VRTX scores higher overall (66/100 vs 59/100), backed by strong 35.5% margins. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Advanced Energy Industries Inc

INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA

Advanced Energy Industries, Inc. designs, manufactures, sells and supports precision energy conversion, measurement and control solutions globally. The company is headquartered in Denver, Colorado.

Vertex Pharmaceuticals Inc

HEALTHCARE · BIOTECHNOLOGY · USA

Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.

Want to dig deeper into these stocks?